China NT Pharma Group Company Limited
HKEX:1011.HK
0.305 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash & Cash Equivalents
| 1.52 | 5.931 | 9.443 | 7.694 | 28.198 | 87.793 | 146.868 | 89.624 | 327.995 | 346.062 | 229.239 | 246.03 | 373.755 | 154.913 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 44.79 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 1.52 | 5.931 | 9.443 | 7.694 | 72.988 | 87.793 | 146.868 | 89.624 | 327.995 | 349.062 | 229.239 | 246.03 | 373.755 | 154.913 |
| Net Receivables
| 10.052 | 33.666 | 12.452 | 25.964 | 63.58 | 242.384 | 652.106 | 722.769 | 236.823 | 252.33 | 98.039 | 0 | 2,409.432 | 1,738.213 |
| Inventory
| 0 | 10.318 | 32.005 | 27.287 | 34.461 | 44.962 | 65.313 | 167.062 | 174.834 | 84.24 | 132.409 | 242.92 | 355.673 | 527.054 |
| Other Current Assets
| 0.705 | 23.519 | 213.803 | 516.014 | 138.315 | 457.336 | 876.962 | 5.139 | 329.849 | 614.576 | 705.407 | 1,338.371 | 112.103 | 47.08 |
| Total Current Assets
| 12.277 | 73.434 | 267.703 | 576.959 | 309.344 | 590.091 | 1,089.143 | 984.594 | 832.678 | 1,047.878 | 1,067.055 | 1,827.321 | 3,250.963 | 2,467.26 |
| Non-Current Assets: | ||||||||||||||
| Property, Plant & Equipment, Net
| 0.944 | 495.717 | 248.365 | 537.828 | 305.415 | 621.474 | 292.34 | 309.6 | 344.465 | 302.947 | 204.007 | 264.699 | 245.409 | 241.336 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.25 | 1.25 |
| Intangible Assets
| 0.195 | 158.985 | 160.835 | 162.846 | 1,166.053 | 1,288.36 | 1,301.926 | 1,156.7 | 133.425 | 38.524 | 44.821 | 23.014 | 48.826 | 37.174 |
| Goodwill and Intangible Assets
| 0.195 | 158.985 | 160.835 | 162.846 | 1,166.053 | 1,288.36 | 1,301.926 | 1,156.7 | 133.425 | 38.524 | 44.821 | 23.014 | 50.076 | 38.424 |
| Long Term Investments
| 313.546 | 277.582 | 278.457 | 17.436 | -27.328 | 17.477 | 19.425 | 11.969 | 477.89 | 341.471 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | -277.582 | -278.457 | -17.436 | 0 | -17.477 | 56.885 | 57.745 | 87.745 | 96.083 | 109.763 | 88.398 | 22.191 | 5.919 |
| Other Non-Current Assets
| 2.16 | 277.582 | 278.457 | 17.436 | 44.79 | -272.763 | 0 | 42.131 | -477.89 | -341.471 | 16 | 21.56 | 2.397 | 2.397 |
| Total Non-Current Assets
| 316.845 | 932.284 | 687.657 | 718.11 | 1,488.93 | 1,637.071 | 1,670.576 | 1,578.145 | 565.635 | 437.554 | 374.591 | 397.671 | 320.073 | 288.076 |
| Total Assets
| 329.122 | 1,005.718 | 955.36 | 1,295.069 | 1,798.274 | 2,227.162 | 2,759.719 | 2,562.739 | 1,398.313 | 1,485.432 | 1,441.646 | 2,224.992 | 3,571.036 | 2,755.336 |
| Liabilities & Equity: | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Account Payables
| 0.974 | 37.742 | 44.63 | 46.697 | 34.737 | 17.839 | 131.77 | 64.628 | 23.178 | 474.817 | 434.206 | 609.536 | 902.602 | 1,358.27 |
| Short Term Debt
| 341.342 | 825.991 | 618.43 | 799.404 | 959.614 | 1,007 | 656.055 | 892.449 | 261.17 | 544.242 | 315.089 | 526.17 | 526.253 | 840.187 |
| Tax Payables
| 0.122 | 32.246 | 20.766 | 15.1 | 21.079 | 12.557 | 34.014 | 26.103 | 18.724 | 14.978 | 31.864 | 16.964 | 85.639 | 51.941 |
| Deferred Revenue
| -0.634 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 323.405 | 305.96 | 232.913 | 310.335 | 631.166 | 316.146 | 419.178 | 410.502 | 211.242 | 110.562 | 172.74 | 183.239 | 85.639 | 51.941 |
| Total Current Liabilities
| 665.087 | 1,169.693 | 895.973 | 1,156.436 | 1,625.517 | 1,340.985 | 1,207.003 | 1,367.579 | 495.59 | 1,129.621 | 922.035 | 1,318.945 | 1,514.494 | 2,250.398 |
| Non-Current Liabilities: | ||||||||||||||
| Long Term Debt
| 3.6 | 0.463 | 213.68 | 52.051 | 67.992 | 3.55 | 0 | 0 | 0 | 120 | 309.941 | 20 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | -77.22 | 213.29 | 0 | 0 | 0 | 0 | 0 | 0 | 22.216 | 309.941 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 77.22 | 57.082 | 63.688 | 0 | 0 | 0 | 0 | 0 | 0.616 | 0.871 | 1.053 | 1.235 | 2.661 |
| Other Non-Current Liabilities
| 0 | 77.22 | -213.29 | 0.472 | 2.842 | 391.058 | 123.963 | 156.138 | 284.348 | 0 | -309.941 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 3.6 | 77.683 | 270.762 | 116.211 | 70.834 | 394.608 | 123.963 | 156.138 | 284.348 | 142.832 | 310.812 | 21.053 | 1.235 | 2.661 |
| Total Liabilities
| 668.687 | 1,247.376 | 1,166.735 | 1,272.647 | 1,696.351 | 1,735.593 | 1,330.966 | 1,523.717 | 495.59 | 1,272.453 | 1,232.847 | 1,339.998 | 1,515.729 | 2,253.059 |
| Equity: | ||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 276.131 | 276.131 | 329.714 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 |
| Retained Earnings
| -2,505.605 | -2,732.093 | -2,625.54 | -2,459.273 | -2,379.911 | -1,706.026 | -861.387 | -1,010.66 | -1,113.592 | -1,206.434 | -1,214.211 | -549.169 | 0 | 0 |
| Accumulated Other Comprehensive Income/Loss
| -339.566 | 638.236 | 566.855 | 628.242 | -276.131 | -147.656 | -125.842 | -107.762 | -92.154 | -79.252 | -72.333 | -57.206 | -41.359 | -30.496 |
| Other Total Stockholders Equity
| 2,505.605 | 1,852.198 | 1,847.309 | 1,847.309 | 2,485.168 | 2,066.842 | 2,077.894 | 2,145.504 | 2,096.108 | 1,498.664 | 1,495.342 | 1,491.368 | 2,081.535 | 517.643 |
| Total Shareholders Equity
| -339.565 | -241.658 | -211.375 | 16.279 | 105.258 | 489.292 | 1,420.38 | 1,027.083 | 890.363 | 212.979 | 208.799 | 884.994 | 2,040.177 | 487.147 |
| Total Equity
| -339.565 | -241.658 | -211.375 | 22.422 | 101.923 | 491.569 | 1,428.753 | 1,039.022 | 902.723 | 212.979 | 208.799 | 884.994 | 2,055.307 | 502.277 |
| Total Liabilities & Shareholders Equity
| 329.122 | 1,005.718 | 955.36 | 1,295.069 | 1,798.274 | 2,227.162 | 2,759.719 | 2,562.739 | 1,398.313 | 1,485.432 | 1,441.646 | 2,224.992 | 3,571.036 | 2,755.336 |